tepotinib
merck
['lung', 'tepotinib']
presented today at #asco23, tepotinib treatment in patients with met exon 14 skipping non small cell lung cancer: long-term follow-up of the vision phase 2 nonrandomized clinical trial , from . free to read online during the meeting 
Home of @JAMA_Current, @JAMANetworkOpen, @JAMAHealthForum, & 10 specialty journals that publish science and opinion shaping #medicine today and into the future.